​

Soligenix (SNGX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SNGX Stock Rating

Soligenix stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

SNGX Price Target Upside V Benchmarks

TypeNameUpside
StockSoligenix-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$1.89$1.89$1.89
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25------
May, 25------
Apr, 25-1---1
Mar, 25-1---1
Feb, 25-1---1
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

$-200 $-160 $-120 $-80 $-40 $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-154.45$-75.06$-76.96$-12.66$-5.23--
Avg Forecast$-120.48$-69.60$-72.00$-13.28$-7.10$-6.75$-3.25
High Forecast$-114.56$-66.18$-67.75$-12.37$-6.61$-6.29$-3.03
Low Forecast$-126.40$-73.02$-76.25$-14.19$-7.59$-7.21$-3.47
Surprise %28.20%7.84%6.89%-4.67%-26.34%--

Revenue Forecast

$0 $500K $1M $2M $2M $3M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$2.36M$824.27K$948.91K$839.36K$119.37K--
Avg Forecast$2.20M$666.00K$783.00K$795.00K$519.00K$800.00K$800.00K
High Forecast$2.28M$691.17K$818.59K$836.84K$546.32K$842.11K$842.11K
Low Forecast$2.11M$640.82K$747.41K$753.16K$491.68K$757.89K$757.89K
Surprise %7.41%23.76%21.19%5.58%-77.00%--

Net Income Forecast

$-65M $-52M $-39M $-26M $-13M $0 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-17.69M$-12.55M$-13.80M$-6.14M$-8.68M--
Avg Forecast$-58.42M$-11.46M$-13.04M$-6.14M$-3.44M$-3.27M$-1.58M
High Forecast$-55.55M$-9.17M$-10.44M$-4.91M$-3.21M$-3.05M$-1.47M
Low Forecast$-61.29M$-13.75M$-15.65M$-7.37M$-3.68M$-3.50M$-1.68M
Surprise %-69.72%9.50%5.78%-152.01%--

SNGX Forecast FAQ

Is Soligenix stock a buy?

Soligenix stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Soligenix is a favorable investment for most analysts.

What is Soligenix's price target?

Soligenix's price target, set by 7 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $1.89.

How does Soligenix stock forecast compare to its benchmarks?

Soligenix's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for Soligenix over the past three months?

  • April 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Soligenix’s EPS forecast?

Soligenix's average annual EPS forecast for its fiscal year ending in December 2025 is $-6.75, marking a 29.06% increase from the reported $-5.23 in 2024. Estimates for the following years are.

What is Soligenix’s revenue forecast?

Soligenix's average annual revenue forecast for its fiscal year ending in December 2025 is $800K, reflecting a 570.18% increase from the reported $119.37K in 2024. The forecast for.

What is Soligenix’s net income forecast?

Soligenix's net income forecast for the fiscal year ending in December 2025 stands at $-3.273M, representing a -62.27% decrease from the reported $-8.676M in 2024. Projections indicate .